Shandong Tianming Pharmaceutical, a GMP-certified leader in advanced API and intermediate manufacturing, will unveil its latest innovations at CPHI China 2025 (June 24-26, Shanghai New International Expo Centre).
Visit us at Booth W2G30 to explore cutting-edge solutions reshaping pharmaceutical synthesis.
As an eight-time exhibitor with proven industry partnerships, we deliver more than products – we offer actionable pathways to:
1/Explore cutting-edge API synthesis technology and break through R&D bottlenecks
2/Unlock customized solutions:
3/Overcome Regulatory Hurdles
4/Global compliance escort, opening up international market access channels
– GLP-1 Agonist Intermediates: >99.9% chiral purity for obesity/diabetes pipelines
– Antibiotic Resistance Fighters: β-lactamase inhibitor scaffolds with 80% oral bioavailability
– On-Demand Synthesis: From R&D samples to commercial batches
With 300+ commercial APIs and 15 years of GMP excellence, Tianming enables partners across 40 countries to overcome synthesis scalability, compliance, and sustainability challenges.
We look forward to seeing you at CPHI China 2025!
Best regards
Sales Team
Shandong Tianming Pharmaceutical Group
Learn which foods are rich in PQQ and how to maintain a balanced intake. Adding these foods to your diet helps enhance cognitive function, fight fatigue, and protect overall health.
The European Food Safety Authority (EFSA) has begun the approval process for NMN as a novel food, marking a breakthrough in global compliance. This milestone may accelerate NMN’s role in anti-aging, energy metabolism, and health supplements, shaping a new era in nutrition and wellness.
This guide clarifies distinctions between brand-name drugs, generics, and APIs, emphasizing bioequivalence, cost efficiency for chronic conditions, and safety warnings.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.